Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Category: Patent Legislation
-
By Donald Zuhn — Earlier this month, Science Progress, a semi-annual journal published by the Center for American Progress, issued a series of reports on the U.S. patent system. The series, outlined in an article entitled: "Patent Reform 101," consists of four reports: • "Tackling the Challenge of Patent Reform: Recommendations for the Obama…
-
By Donald Zuhn — In an interview with TechJournal South, Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood discussed the state of the biotech industry and the biotech issues the new Administration will be facing in the coming year (see "BIO President Sees Biotech Industry Challenges for New Administration"). Mr. Greenwood told the…
-
By Donald Zuhn — Last week, Science Progress, a semi-annual journal published by the Center for American Progress, a liberal think tank headed by John Podesta, former White House Chief of Staff under President Clinton (as well as recent co-chairman of the Obama-Biden transition team), issued a series of reports on the U.S. patent…
-
By Donald Zuhn — Earlier today, in a historic moment on the steps of the U.S. Capitol, Barack Hussein Obama was sworn in as the 44th President of the United States. Tomorrow, his Administration will begin to tackle the many serious issues that face our country (the Administration's agenda can be found on the…
-
By Donald Zuhn — Yesterday, the Manufacturing Alliance on Patent Policy (MAPP) released a report which indicates that the apportionment of damages provisions found in the Senate (S. 1145) and House (H.R. 1908) patent reform bills would have several adverse effects. The apportionment of damages provisions in these bills attempt to apportion the value…
-
By Donald Zuhn — Yesterday, we counted down stories #9 to #6 of the top stories covered at Patent Docs in 2008 (see "Top Stories of 2008: #9 to #6"), and on New Year's Day, we listed stories #13 to #10 (see "Top Stories of 2008: #13 to #10"). Today, we conclude our second…
-
By Donald Zuhn — Earlier this month, we reported on the lobbying efforts of nine biotech/pharma companies and organizations in the third quarter of 2008 (see "Biotech/Pharma Lobbying Scoreboard – Third Quarter Update; BIO Lobbies for Biotech 'Bailout'"). Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to…
-
By Donald Zuhn — Patent Docs periodically reports on the lobbying efforts of various players in the biotech/pharma industry (see links below for reports on first and second quarter lobbying this year). Our interest in the lobbying expenditures of these companies and organizations stems from the push by Congress over the past two years…
-
By Donald Zuhn — An article in the October 10th issue of Science magazine presents the results of an analysis of litigated gene patents, and reaches the conclusion that "for the most part, fears expressed concerning human gene patents have not been manifested overtly in patent litigation." The article, entitled "Trends in Human Gene…
-
By Kevin E. Noonan — Roll Call, the Newspaper of Capitol Hill since 1955, announced today that Rep. Xavier Becerra (D-CA, 31st Dist.) "appears poised to accept a post as U.S. trade representative" in the Obama administration. We here at Patent Docs, and all reasoning members of the patent community, wish Rep. Becerra (at…
Patent Docs 